Christine Feng, DO, PGY3, et al. “New-Onset Diabetic Ketoacidosis Secondary to Nivolumab Therapy in a Patient With Primary Central Nervous System Lymphoma”. Osteopathic Family Physician, vol. 13, no. 3, May 2021, pp. 40-43, doi:10.33181/13037.